Aging and venous thromboembolism influence the pharmacodynamics of the anti-factor Xa and anti-thrombin activities of a low-molecular-weight heparin (nadroparin) - Mismetti,P.; Laporte-Simitsidis,S.; Navarro,C. (Thromb Haemost, 1998)